These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26729528)

  • 1. Studies on Aspirin Crystals Generated by a Modified Vapor Diffusion Method.
    Mittal A; Malhotra D; Jain P; Kalia A; Shunmugaperumal T
    AAPS PharmSciTech; 2016 Aug; 17(4):988-94. PubMed ID: 26729528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and in vivo evaluation of pharmacological activity of different crystal forms of ibuprofen.
    Li Y; Yao F; Shang C; Ren F; Zhang J; Li Y; Yang G; Lin R; Wang W
    Pak J Pharm Sci; 2019 Sep; 32(5):2139-2147. PubMed ID: 31813880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal modification of dipyridamole using different solvents and crystallization conditions.
    Adhiyaman R; Basu SK
    Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced dissolution rate of simvastatin using spherical crystallization technique.
    Varshosaz J; Tavakoli N; Salamat FA
    Pharm Dev Technol; 2011 Oct; 16(5):529-35. PubMed ID: 20684739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
    Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal modification of phenytoin using different solvents and crystallization conditions.
    Nokhodchi A; Bolourtchian N; Dinarvand R
    Int J Pharm; 2003 Jan; 250(1):85-97. PubMed ID: 12480275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Co-crystals of Glipizide with Enhanced Dissolution Profiles: Preparation and Characterization.
    Pandey NK; Sehal HR; Garg V; Gaur T; Kumar B; Singh SK; Gulati M; Gowthamarajan K; Bawa P; Rajesh SY; Sharma P; Narang R
    AAPS PharmSciTech; 2017 Oct; 18(7):2454-2465. PubMed ID: 28176212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supercritical fluid crystallization of griseofulvin: crystal habit modification with a selective growth inhibitor.
    Jarmer DJ; Lengsfeld CS; Anseth KS; Randolph TW
    J Pharm Sci; 2005 Dec; 94(12):2688-702. PubMed ID: 16258994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal modifications and dissolution rate of piroxicam.
    Lyn LY; Sze HW; Rajendran A; Adinarayana G; Dua K; Garg S
    Acta Pharm; 2011 Dec; 61(4):391-402. PubMed ID: 22202198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new polymorph of isoimperatorin.
    Fu J; Dong X; Yin X; Yang C; Wang W; Du X; Zhang X; Ni J
    Pharm Dev Technol; 2018 Nov; 23(9):849-856. PubMed ID: 27808578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of submicron-sized niflumic acid crystals prepared by electrospray crystallization.
    Ambrus R; Radacsi N; Szunyogh T; van der Heijden AE; Ter Horst JH; Szabó-Révész P
    J Pharm Biomed Anal; 2013 Mar; 76():1-7. PubMed ID: 23287488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisinopril dihydrate: single-crystal x-ray structure and physicochemical characterization of derived solid forms.
    Sorrenti M; Catenacci L; Cruickshank DL; Caira MR
    J Pharm Sci; 2013 Oct; 102(10):3596-603. PubMed ID: 23873413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.
    Borgmann SH; Bernardi LS; Rauber GS; Oliveira PR; Campos CE; Monti G; Cuffini SL; Cardoso SG
    Pharm Dev Technol; 2013; 18(2):525-34. PubMed ID: 23033850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
    Patil SV; Pawar AP; Sahoo SK
    Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorph screening of an active material.
    Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
    J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New conformational polymorph of hydrochlorothiazide with improved solubility.
    Saini A; Chadha R; Gupta A; Singh P; Bhandari S; Khullar S; Mandal S; Jain DS
    Pharm Dev Technol; 2016 Aug; 21(5):611-8. PubMed ID: 25975587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.